Why IonQ Stock Plummeted 31.5% in October

In October, IonQ's (IONQ +9.23%) stock experienced a significant 31.5% decline, following a 12% increase in September. The decline was primarily driven by investor concerns over the company's planned acquisition of Elisity, a firm specializing in a zero-trust platform. IonQ's announcement of this acquisition in early October sent investors into a frenzy, with many choosing to sell their shares.

Elisity's strong year-over-year growth, with no churn among its deployed customers, was seen as a positive but the company's projected share dilution following the acquisition was a major source of worry.

Compounding the issue, IonQ announced in early October a $2 billion equity offering, with 20.5 million shares of IonQ common stock and pre-funded warrants for an additional 29.5 million shares. This further heightened investor fears of dilution. Following these developments, IonQ's stock was met with skepticism from Wall Street analysts.

Rosenblatt lowered its price target for IonQ to $70 from $100, while Morgan Stanley's Joseph Moore reduced his price target to $43 from $49. Both analysts expressed uncertainties about the commercial adoption of the quantum computing industry, despite acknowledging its potential to reach $100 billion by 2040.

Despite these challenges, IonQ remains a major player in the quantum computing field, offering integrated solutions in computing, networking, sensing, and security. As of September 2026, the company's backlog was valued at $1.2 billion. However, the stock's fortunes began to turn in November, with a more than 18% increase in value after the company released strong third-quarter 2026 financial results on November 5th.

While concerns about share dilution are not entirely unfounded, the long-term growth potential of IonQ in the quantum computing industry makes it a compelling long-term investment opportunity.